<table id="_Refid_e3471acf-e459-442f-a44f-299306a4d" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8.  Bioavailability of Divalproex Sodium Extended-release Tablets Relative to Divalproex Sodium Delayed-release Tablets When Divalproex Sodium Extended-release Tablets Dose is 8% to 20% Higher</caption>
<col width="54%"></col>
<col width="37%"></col>
<col width="9%"></col>
<col width="8%"></col>
<col width="8%"></col>
<tbody>
<tr>
<td align="center" stylecode="Toprule " valign="top">
<paragraph>
<content stylecode="bold">Study Population</content>
</paragraph>
</td>
<td align="center" stylecode="Toprule " valign="top">
<paragraph>
<content stylecode="bold">Regimens</content>
</paragraph>
</td>
<td align="center" colspan="3" stylecode="Toprule " valign="top">
<paragraph>
<content stylecode="bold">Relative Bioavailability</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule " valign="top"></td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>Divalproex Sodium Extended-release TabletsÂ  vs.<br/>
</paragraph>
<paragraph>Divalproex Sodium Delayed-Release Tablets</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>AUC<sub>24</sub>
</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>C<sub>max</sub>
</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>C<sub>min</sub>
</paragraph>
</td>
</tr>
<tr>
<td align="center" valign="top">
<paragraph>Healthy Volunteers<br/>(n = 35)</paragraph>
</td>
<td align="center" valign="top">
<paragraph>1000 mg &amp; 1500 mg<br/>Divalproex Sodium Extended-release Tablets vs.<br/>875 mg &amp; 1250 mg<br/>
</paragraph>
<paragraph>Divalproex Sodium Delayed-release Tablets</paragraph>
</td>
<td align="center" valign="top">
<paragraph>1.059</paragraph>
</td>
<td align="center" valign="top">
<paragraph>0.882</paragraph>
</td>
<td align="center" valign="top">
<paragraph>1.173</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs<br/>(n = 64)</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>1000 mg to 5000 mg<br/>Divalproex Sodium Extended-release Tablets vs.<br/>875 mg to 4250 mg<br/>
</paragraph>
<paragraph>Divalproex Sodium Delayed-release Tablets</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>1.008</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>0.899</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="top">
<paragraph>1.022</paragraph>
</td>
</tr>
</tbody>
</table>